| Dr Yana Ryzhakova, NURSE PRACTITIONER | |
|
2232 Kimball St, Brooklyn, NY 11234-5148 | |
| (718) 684-4490 | |
| (718) 684-4498 |
| Full Name | Dr Yana Ryzhakova |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 2232 Kimball St, Brooklyn, New York |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033576863 | NPI | - | NPPES |
| Entity Name | Medex Diagnostic And Treatment Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629001102 PECOS PAC ID: 1456336445 Enrollment ID: O20040623000574 |
News Archive
The U.S. Department of Labor's Occupational Safety and Health Administration (OSHA) has unveiled new safety and health guidance that will help healthcare workers and their employers prepare for a possible influenza pandemic.
Exiqon A/S announced today that the Harvard Medical School ICCB-Longwood Screening Facility (ICCB-L) has been recognized as a MicroRNA Screening Center of Excellence.
Collectively, such diseases of the airways as emphysema, bronchitis, asthma and cystic fibrosis are the second leading cause of death worldwide. More than 35 million Americans alone suffer from chronic respiratory disease. Weizmann Institute scientists have now proposed a new direction that could, in the future, lead to the development of a method for alleviating some of their suffering.
Domainex Ltd., the Contract Research Organization committed to excellence in drug discovery, today announced a collaboration with Sigma-Aldrich that will provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics. These epigenetic proteins regulate DNA expression and can be critical to cancer and stem cell biology research. Funding from the UK Government-backed Technology Strategy Board will support this work.
Cost Estimate: S 1082, Prescription Drug User Fee Amendments of 2007," Congressional Budget Office: The CBO report details proposed changes to the Prescription Drug User Fee Act and outlines spending and costs to federal and state governments.
› Verified 5 days ago
| Entity Name | Ny Priority Medical Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144506056 PECOS PAC ID: 1759542582 Enrollment ID: O20120423000068 |
News Archive
The U.S. Department of Labor's Occupational Safety and Health Administration (OSHA) has unveiled new safety and health guidance that will help healthcare workers and their employers prepare for a possible influenza pandemic.
Exiqon A/S announced today that the Harvard Medical School ICCB-Longwood Screening Facility (ICCB-L) has been recognized as a MicroRNA Screening Center of Excellence.
Collectively, such diseases of the airways as emphysema, bronchitis, asthma and cystic fibrosis are the second leading cause of death worldwide. More than 35 million Americans alone suffer from chronic respiratory disease. Weizmann Institute scientists have now proposed a new direction that could, in the future, lead to the development of a method for alleviating some of their suffering.
Domainex Ltd., the Contract Research Organization committed to excellence in drug discovery, today announced a collaboration with Sigma-Aldrich that will provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics. These epigenetic proteins regulate DNA expression and can be critical to cancer and stem cell biology research. Funding from the UK Government-backed Technology Strategy Board will support this work.
Cost Estimate: S 1082, Prescription Drug User Fee Amendments of 2007," Congressional Budget Office: The CBO report details proposed changes to the Prescription Drug User Fee Act and outlines spending and costs to federal and state governments.
› Verified 5 days ago
| Entity Name | Prn Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427416189 PECOS PAC ID: 9830481597 Enrollment ID: O20160718000256 |
News Archive
The U.S. Department of Labor's Occupational Safety and Health Administration (OSHA) has unveiled new safety and health guidance that will help healthcare workers and their employers prepare for a possible influenza pandemic.
Exiqon A/S announced today that the Harvard Medical School ICCB-Longwood Screening Facility (ICCB-L) has been recognized as a MicroRNA Screening Center of Excellence.
Collectively, such diseases of the airways as emphysema, bronchitis, asthma and cystic fibrosis are the second leading cause of death worldwide. More than 35 million Americans alone suffer from chronic respiratory disease. Weizmann Institute scientists have now proposed a new direction that could, in the future, lead to the development of a method for alleviating some of their suffering.
Domainex Ltd., the Contract Research Organization committed to excellence in drug discovery, today announced a collaboration with Sigma-Aldrich that will provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics. These epigenetic proteins regulate DNA expression and can be critical to cancer and stem cell biology research. Funding from the UK Government-backed Technology Strategy Board will support this work.
Cost Estimate: S 1082, Prescription Drug User Fee Amendments of 2007," Congressional Budget Office: The CBO report details proposed changes to the Prescription Drug User Fee Act and outlines spending and costs to federal and state governments.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yana Ryzhakova, NURSE PRACTITIONER 4207 Atlantic Ave # 1b, Brooklyn, NY 11224-1023 Ph: (646) 696-1150 | Dr Yana Ryzhakova, NURSE PRACTITIONER 2232 Kimball St, Brooklyn, NY 11234-5148 Ph: (718) 684-4490 |
News Archive
The U.S. Department of Labor's Occupational Safety and Health Administration (OSHA) has unveiled new safety and health guidance that will help healthcare workers and their employers prepare for a possible influenza pandemic.
Exiqon A/S announced today that the Harvard Medical School ICCB-Longwood Screening Facility (ICCB-L) has been recognized as a MicroRNA Screening Center of Excellence.
Collectively, such diseases of the airways as emphysema, bronchitis, asthma and cystic fibrosis are the second leading cause of death worldwide. More than 35 million Americans alone suffer from chronic respiratory disease. Weizmann Institute scientists have now proposed a new direction that could, in the future, lead to the development of a method for alleviating some of their suffering.
Domainex Ltd., the Contract Research Organization committed to excellence in drug discovery, today announced a collaboration with Sigma-Aldrich that will provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics. These epigenetic proteins regulate DNA expression and can be critical to cancer and stem cell biology research. Funding from the UK Government-backed Technology Strategy Board will support this work.
Cost Estimate: S 1082, Prescription Drug User Fee Amendments of 2007," Congressional Budget Office: The CBO report details proposed changes to the Prescription Drug User Fee Act and outlines spending and costs to federal and state governments.
› Verified 5 days ago